Biotest AG is a DE-based company operating in Biotechnology industry. The company is headquartered in Dreieich, Hessen and currently employs 2,495 full-time employees. Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. The company develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.
How did BTTAY's recent EPS compare to expectations?
The most recent EPS for Biotest Aktiengesellschaft is $, expectations of $.
How did Biotest Aktiengesellschaft BTTAY's revenue perform in the last quarter?
Biotest Aktiengesellschaft revenue for the last quarter is $
What is the revenue estimate for Biotest Aktiengesellschaft?
According to of Wall street analyst, the revenue estimate of Biotest Aktiengesellschaft range from $ to $
What's the earning quality score for Biotest Aktiengesellschaft?
Biotest Aktiengesellschaft has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Biotest Aktiengesellschaft report earnings?
Biotest Aktiengesellschaft next earnings report is expected in 2026-02-08
What are Biotest Aktiengesellschaft's expected earnings?
Biotest Aktiengesellschaft expected earnings is $, according to wall-street analysts.
Did Biotest Aktiengesellschaft beat earnings expectations?
Biotest Aktiengesellschaft recent earnings of $ expectations.